| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/24/2013 | US8541399 Solvent-based sterilisation of pharmaceuticals |
| 09/24/2013 | US8541375 Glycopeptide phosphonate derivatives |
| 09/24/2013 | US8541359 Pharmaceutical compositions and methods for peptide treatment |
| 09/24/2013 | US8541230 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 09/24/2013 | US8541030 Preparation method of sustained-release microcapsules having initial burst inhibiting property and the microcapsules thereby |
| 09/24/2013 | US8541029 Article and method for focused delivery of therapeutic and/or diagnostic materials |
| 09/24/2013 | US8541028 Methods for manufacturing delivery devices and devices thereof |
| 09/24/2013 | US8541027 Fixation devices for tissue repair |
| 09/24/2013 | US8541026 Sustained release formulations of opioid and nonopioid analgesics |
| 09/24/2013 | US8541025 Co-crystals and pharmaceutical formulations comprising the same |
| 09/24/2013 | US8541024 Film-coated scored tablet |
| 09/24/2013 | US8541023 Immunogenic compositions containing phospholipid |
| 09/24/2013 | US8541020 Washable, water resistant adhesive; crosslinked copolymer from such as acrylamide, diethyleneglycol methacrylate, n,n-methylenebisacrylamide, hexaglycerin and polyethyleneglycol; reusable bioelectrodes |
| 09/24/2013 | US8541019 Palatable ductile chewable veterinary composition |
| 09/24/2013 | US8541017 Use of alginate matrices to control cell growth |
| 09/24/2013 | US8541013 Amphiphilic terpolymer having pH-sensitive hydrophobic units derived from a polyunsaturated fatty acid (9,12-Octadecadienoic Acid), hydrophilic units with polar groups (acrylic acid), and temperature-sensitive units (acryloylpiperidine), useful for drug delivery |
| 09/24/2013 | US8540980 Delivery system for biological component |
| 09/24/2013 | US8540970 Composition for treating xerostomia or dry mouth |
| 09/24/2013 | US8540969 Aerosol dispersions of particles with active pharmaceutical ingredients |
| 09/24/2013 | US8540631 Apparatus and methods using acoustic telemetry for intrabody communications |
| 09/24/2013 | CA2694403C Topical antibiotic composition for the prevention of lyme disease |
| 09/24/2013 | CA2689856C Composition and method for stable injectable liquids |
| 09/24/2013 | CA2658491C Membrane-translocating peptides |
| 09/24/2013 | CA2633489C Compositions and methods for treating dermatological conditions |
| 09/24/2013 | CA2604770C Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof |
| 09/24/2013 | CA2601454C Antibacterial 5,5'-disubstituted 3,3'-dialkoxy-2,2'-dihydroxy-1,1'-biphenyl compounds and related methods |
| 09/24/2013 | CA2598827C An hiv protease inhibitor solid dosage formulation for the treatment of hiv/aids under fasting conditions |
| 09/24/2013 | CA2595517C Drug carrier and drug carrier kit for inhibiting fibrosis |
| 09/24/2013 | CA2584343C Pharmaceutical compositions comprising a camptothecin derivate |
| 09/24/2013 | CA2578176C Ophthalmic emulsions containing an immunosuppressive agent |
| 09/24/2013 | CA2568914C Therapeutic agents, and methods of making and using the same |
| 09/24/2013 | CA2566007C Drug delivery liposomes containing anionic polyols or anionic sugars |
| 09/24/2013 | CA2553444C Rapidly disintegrating gelatinous coated tablets |
| 09/24/2013 | CA2517010C Plasmid dna in combination with recombinant vsv for use in prime-boost immunization regimens |
| 09/24/2013 | CA2497452C Compositions and process for delivering an additive |
| 09/24/2013 | CA2480656C Bioadhesive directed somatic cell therapy |
| 09/24/2013 | CA2466697C Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 09/19/2013 | WO2013138783A1 A NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULES |
| 09/19/2013 | WO2013138744A1 Compositions for the treatment of skin disorders |
| 09/19/2013 | WO2013138520A1 Composition and system for transdermal delivery |
| 09/19/2013 | WO2013138427A1 Microvesicle-mediated delivery of therapeutic molecules |
| 09/19/2013 | WO2013137839A1 Tablet formulation comprising dapagliflozin and extended release metformin |
| 09/19/2013 | WO2013137778A1 Solid dosage form having neuroprotector, antiamnesic, antioxidant, antihypoxic, and antiischaemic activity (alternatives) |
| 09/19/2013 | WO2013137755A1 Process for the preparation of polysaccharide nanoparticles |
| 09/19/2013 | WO2013137748A1 Long acting compositions |
| 09/19/2013 | WO2013137694A1 Solid matter for water-insoluble material coated with amorphous surfactant containing fatty acid having straight alkyl chain 직쇄 알킬체인을 가진 지방산을 포함하는 무수무복계면물질 |
| 09/19/2013 | WO2013137692A1 Method for manufacturing water-insoluble substance coated with amorphous surfactant and solid substance which becomes water-insoluble substance coated with amorphous surfactant when in water |
| 09/19/2013 | WO2013137441A1 Oral pharmaceutical composition |
| 09/19/2013 | WO2013137009A1 Ameliorating agent for chronic obstructive pulmonary disease |
| 09/19/2013 | WO2013136234A1 Transdermal delivery devices |
| 09/19/2013 | WO2013136094A1 Porous carbon particles for use in the treatment or prevention of liver disease |
| 09/19/2013 | WO2013136075A1 Novel pharmaceutical formulations |
| 09/19/2013 | WO2013135892A1 Liposomal delivery system |
| 09/19/2013 | WO2013135853A1 Pharmaceutical packaging product for the veterinary medical sector |
| 09/19/2013 | WO2013135852A1 Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
| 09/19/2013 | WO2013135800A1 Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood |
| 09/19/2013 | WO2013135727A1 Glioma treatment by convection enhanced delivery |
| 09/19/2013 | WO2013135571A1 Compositions with enhanced therapeutic efficacy against infective agents of the eye comprising miltefosine and polyhexamethylene biguanide |
| 09/19/2013 | WO2013135360A1 Aminoacid lipids |
| 09/19/2013 | WO2013135359A1 Targeting aminoacid lipids |
| 09/19/2013 | WO2013135211A1 System and method for generation of emulsions with low interfacial tension and measuring frequency vibrations in the system |
| 09/19/2013 | WO2013135189A1 Solid dispersion improving absorption performance and preparation of same |
| 09/19/2013 | WO2013135187A1 Solid dispersion of improved adsorption performance and preparation thereof |
| 09/19/2013 | WO2013135103A1 Polypeptide carrying melittin, nanoparticle carrying melittin and use thereof |
| 09/19/2013 | WO2013113027A3 Enclosing materials in natural transport systems |
| 09/19/2013 | WO2013112762A4 Bendamustine compositions and methods therefore |
| 09/19/2013 | WO2013104892A8 Application of high dose compounds via inhalation |
| 09/19/2013 | WO2012117257A8 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer |
| 09/19/2013 | US20130245577 Method and Apparatus for Alcohol Administration and Therapeutic Treatments Using Same |
| 09/19/2013 | US20130245528 Compositions Comprising Placental Collagen for Use in Wound Healing |
| 09/19/2013 | US20130245357 Magnetic Nanoparticle Formulations, Methods for Making Such Formulations, and Methods for their Use |
| 09/19/2013 | US20130245154 Controlled release dosage forms |
| 09/19/2013 | US20130245126 Geranylgeranylacetone formulations and retinal delivery thereof |
| 09/19/2013 | US20130245124 Preservative free bimatoprost solutions |
| 09/19/2013 | US20130245109 Pharmaceutical formulation |
| 09/19/2013 | US20130245088 Ketorolac compositions for corneal wound healing |
| 09/19/2013 | US20130245083 Methods of treatment with bioavailable compositions of metaxalone comprising nonvolatile liquids |
| 09/19/2013 | US20130245082 Bioavailable compositions of metaxolone comprising nonvolatile liquids and processes for producing the same |
| 09/19/2013 | US20130245073 Gel containing pirfenidone |
| 09/19/2013 | US20130245069 Formulations and methods for lyophilization and lyophilates provided thereby |
| 09/19/2013 | US20130245060 Novel composition |
| 09/19/2013 | US20130245055 Pharmaceutical Formulation Containing Gelling Agent |
| 09/19/2013 | US20130245004 Acamprosate formulations, methods of using the same, and combinations comprising the same |
| 09/19/2013 | US20130244985 Drug Depots Having Different Release Profiles for Reducing, Preventing or Treating Pain and Inflammation |
| 09/19/2013 | US20130244952 Compositions and methods of delivery of pharmacological agents |
| 09/19/2013 | US20130244880 Novel pesticide formulations |
| 09/19/2013 | US20130243884 Medical Treatment Kit and Methods of Use Thereof |
| 09/19/2013 | US20130243877 Spray-Dried Human Plasma |
| 09/19/2013 | US20130243876 Mir-200 family induces mesenchymal-to-epithelial transition (met) in ovarian cancer cells |
| 09/19/2013 | US20130243875 Threo-dops controlled release formulation |
| 09/19/2013 | US20130243874 Nanoparticles coated with amphiphilic block copolymers |
| 09/19/2013 | US20130243873 Immunomodulatory compositions |
| 09/19/2013 | US20130243872 Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin |
| 09/19/2013 | US20130243871 Dosage forms for oral administration and methods of treatment using the same |
| 09/19/2013 | US20130243870 Hydroxyalkyl cellulose |
| 09/19/2013 | US20130243869 Dosage forms for oral administration and methods of treatment using the same |
| 09/19/2013 | US20130243867 Micelle compositions and methods for their use |
| 09/19/2013 | US20130243866 Silk microspheres for encapsulation and controlled release |
| 09/19/2013 | US20130243864 Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
| 09/19/2013 | US20130243863 Stable Formulations for Lyophilizing Therapeutic Particles |